Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Elevance (ELV) PT Raised to $571 at Jefferies
October 20, 2022 8:48 AM EDTJefferies analyst David Windley raised the price target on Elevance (NYSE: ELV) to $571.00 (from $569.00) while maintaining a Buy rating.
The analyst commented, "LV's membership growth continues to be impressive, having eclipsed UNH in total members in the last 12 months. Government growth plus solid... More
